| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $26.00 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Ault Milton C III | 10% Owner | Buy | 1,000 | $1.04 | $1,040.00 | - | 0.0% | -65.0% | |
| Aug 3, 2022 | Ault Milton C III | 10% Owner | Buy | 2,000 | $0.95 | $1,895.60 | - | +24.6% | -57.0% | |
| Jul 27, 2022 | Ault Milton C III | 10% Owner | Buy | 5,700 | $0.87 | $4,959.00 | - | +28.0% | -46.3% | |
| Jul 22, 2022 | Ault Milton C III | 10% Owner | Buy | 2,300 | $0.91 | $2,081.73 | - | +24.8% | -46.8% | |
| Jul 18, 2022 | Ault Milton C III | 10% Owner | Buy | 10,000 | $0.98 | $9,773.00 | +0.1% | +17.5% | -46.6% | |
| Jun 29, 2022 | Ault Milton C III | 10% Owner | Buy | 10,000 | $0.88 | $8,830.00 | +0.1% | +26.1% | -43.3% | |
| Jun 17, 2022 | Ault Milton C III | 10% Owner | Buy | 10,000 | $0.88 | $8,841.00 | +0.1% | +41.8% | -22.7% | |
| Jun 15, 2022 | Ault Milton C III | 10% Owner | Buy | 10,000 | $0.87 | $8,740.00 | +0.1% | +26.5% | -19.6% | |
| Jun 14, 2022 | Ault Milton C III | 10% Owner | Buy | 10,000 | $0.85 | $8,474.00 | +0.1% | +23.2% | -22.9% | |
| Jun 8, 2022 | Ault Milton C III | 10% Owner | Buy | 8,000 | $0.95 | $7,576.00 | - | +4.5% | -23.6% |